What Stryker knee replacement implants are
Stryker knee replacement implants are orthopedic devices used in total knee arthroplasty, partial knee arthroplasty, and revision procedures. The company’s best-known total knee platform is the Triathlon Total Knee System, which Stryker describes as a primary total knee replacement system with cemented and cementless options and compatibility with its Mako robotic-assisted surgery platform.
For patients, the practical question is not whether one brand is universally “best.” It is whether a specific implant construct, fixation method, surgical plan, and surgeon experience fit the patient’s anatomy, bone quality, activity level, diagnosis, and risk profile. Public sources such as FDA 510(k) records, American Academy of Orthopaedic Surgeons patient materials, and joint registry reports support a careful view: implant design matters, but outcomes also depend heavily on patient selection, surgical execution, rehabilitation, and follow-up.
This overview is educational and should not replace advice from an orthopedic surgeon who can review imaging, medical history, allergies, bone quality, and treatment goals. For related background on orthopedic devices, visit our implants section.
The Stryker knee portfolio in plain English
Stryker’s knee portfolio includes implants for primary total knee replacement, partial knee replacement, and revision knee procedures. In a total knee replacement, damaged cartilage and bone surfaces are removed and replaced with artificial components. AAOS patient education materials explain that a typical total knee implant may include a femoral component at the lower end of the thighbone, a tibial component at the top of the shinbone, a polyethylene insert that acts as the bearing surface, and sometimes a patellar component for the kneecap.
The Triathlon system is the name many patients encounter first when researching Stryker knee replacement implants. It includes different configurations, such as cruciate-retaining, condylar-stabilizing, posterior-stabilized, and more complex primary or revision options. These terms describe how the implant works with the knee’s ligaments and how much built-in stability it provides. They are not interchangeable marketing labels; they influence balancing, range of motion, and the type of knee problem the surgeon is trying to address.
Stryker also markets cementless Triathlon Tritanium components, which use a porous structure intended for bone ingrowth, and Triathlon Gold femoral components, which were introduced as an additional femoral option within the Triathlon system. FDA materials for Triathlon Gold describe titanium alloy components fully coated with titanium nitride and indicated for both cemented and uncemented use. That does not mean every patient with a self-reported metal allergy needs that option, but it gives surgeons another device choice when metal sensitivity concerns are clinically relevant.
Cemented, cementless, and hybrid fixation
One of the most important choices in knee replacement is how the implant is fixed to bone. Cemented fixation uses bone cement to secure components. Cementless fixation relies on initial press-fit stability and later biological fixation as bone grows into or onto a porous surface. Hybrid approaches combine methods, depending on the component and patient factors.
In the United States, cementless fixation has become more visible in recent years. Highlights from the 2025 American Joint Replacement Registry report show cementless use in primary total knee arthroplasty rising from low single digits in 2012 to more than one-fifth of primary TKA cases in 2024. That trend helps explain why Stryker’s cementless Triathlon Tritanium products and Mako-compatible workflows receive attention. A rising trend, however, is not the same as proof that cementless fixation is better for every patient.
International registry data show that practice patterns differ by country. The National Joint Registry for England, Wales, Northern Ireland, the Isle of Man, and Guernsey reported in its 2025 annual report that more than 90% of primary knee replacements in that registry remained all-cemented, with uncemented or hybrid types making up a much smaller share in 2024. This contrast matters because fixation choice reflects surgeon training, patient mix, implant availability, reimbursement systems, and long-term local registry experience.
| Fixation topic | Why it matters | Questions to ask |
|---|---|---|
| Cemented | Long clinical history and widely used in many registries. | Why is cemented fixation preferred for my bone quality and age? |
| Cementless | Designed for biological fixation through porous surfaces, often discussed for active or younger patients with suitable bone. | Am I a good candidate for bone ingrowth fixation, and what evidence supports that choice? |
| Hybrid | May combine advantages depending on component position and bone condition. | Which components will be cemented or cementless, and why? |
How Mako changes planning but not the need for judgment
Mako is Stryker’s robotic-assisted platform used in total knee, partial knee, and hip procedures. For total knee replacement, the system is associated with CT-based planning, intraoperative guidance, and haptic boundaries that help the surgeon carry out a planned bone preparation. Stryker states that Triathlon Total Knee is available for use with Mako Total Knee, and FDA records show clearances related to Triathlon and Mako-compatible components.
For patients, Mako should be understood as a planning and execution technology, not a guarantee of a perfect outcome. It does not remove the need for an experienced surgeon, proper diagnosis, soft-tissue balancing, infection prevention, rehabilitation, and careful follow-up. Registry summaries show that robotic assistance in primary total knee arthroplasty has increased in the United States, approaching 16.1% in aggregate analysis for 2024 in AJRR highlights. That growth signals adoption, but registry authors also note that robotics data can be affected by reporting completeness and selection bias.
When a surgeon recommends a Stryker implant with Mako, patients should ask what the technology is expected to improve in their specific case. Examples may include preoperative planning, component positioning, bone cut execution, or balancing. Patients should also ask what the surgeon would do differently if intraoperative findings do not match the plan.
What current evidence says about durability
Knee implant durability is usually discussed through survivorship, revision rate, and patient-reported outcomes. Survivorship commonly means that the implant has not required revision by a specific time point. It does not necessarily mean the knee feels normal, has no pain, or performs like a natural knee.
Stryker cites a long clinical history for Triathlon and references a 10-year follow-up study reporting 99% survivorship for a single-radius total knee arthroplasty design. That is favorable, but it should be read as evidence for a studied construct and patient group, not as a promise for every Triathlon implant or every patient. Manufacturer materials can be useful, but independent registry data and peer-reviewed studies remain important for context.
AAOS patient materials state that more than 90% of modern total knee replacements are still functioning well 15 years after surgery. The 2025 National Joint Registry report provides additional context, noting that the common cemented unconstrained cruciate-retaining fixed-bearing total knee replacement configuration had a 5.28% revision rate at 20 years in that registry. The same report also emphasizes that implant brand performance can vary by construct, constraint, mobility, and patellar resurfacing status.
In practical terms, no patient should choose Stryker, or any implant brand, based on a single survivorship percentage. A better discussion compares the exact implant construct, the patient’s risk factors, the surgeon’s experience with that system, and the available registry or study data for similar patients. See also: Fixation.
Regulatory records and recalls to understand
In the United States, many knee replacement implants reach the market through the FDA 510(k) pathway, where the agency determines whether a device is substantially equivalent to a legally marketed predicate device for the stated indications. FDA record K173849 lists the Triathlon Total Knee System with a substantially equivalent decision dated February 2, 2018. FDA record K252044 describes Triathlon Gold femoral components as a line extension of previously cleared Triathlon cruciate-retaining femoral components, manufactured from Ti-6Al-4V titanium alloy and fully coated with titanium nitride.
Regulatory language matters. A 510(k) clearance is not the same as a premarket approval finding based on large new clinical trials. It means the FDA found substantial equivalence for the device and indications described in the submission. Patients often hear “FDA approved” in casual conversation, but “FDA cleared” is usually the more accurate term for many Class II orthopedic implants cleared through 510(k).
Recalls also need careful interpretation. FDA recall records show a Class II recall involving certain X3 Triathlon CS insert units, with recall notifications dated February 6, 2024, due to potential packaging breaches of sterile blisters. The FDA record listed 143 units in U.S. commerce and identified specific part and lot numbers. That type of recall does not automatically mean all Stryker knee implants are defective. It does mean hospitals and surgical teams should manage inventory, check affected lot numbers, and follow recall instructions.
| Date or period | Public record or trend | Patient relevance |
|---|---|---|
| February 2, 2018 | FDA 510(k) K173849 listed Triathlon Total Knee System as substantially equivalent. | Confirms a regulatory clearance record for the system, not a guarantee of individual outcome. |
| February 6, 2024 | Recall notifications were sent for specific X3 Triathlon CS insert units due to potential packaging breaches. | Lot-specific recall questions should be handled by the hospital, surgeon, and manufacturer process. |
| 2024 data | AJRR highlights reported rising cementless and robotic-assisted primary TKA utilization in the U.S. | Shows adoption trends, but not universal superiority for every patient. |
| October 2025 FDA record | K252044 described Triathlon Gold femoral components as a titanium alloy, titanium nitride-coated line extension. | Relevant to discussions about femoral component materials and metal sensitivity concerns. |
How to evaluate whether a Stryker knee is right for a patient
Patients usually cannot choose an implant the same way they choose a consumer product. The surgeon’s familiarity with the system, the hospital’s inventory, the robotic platform available, and the patient’s anatomy all influence the final plan. AAOS materials specifically note that implant choice can depend on patient needs, the surgeon’s experience with the device, cost, and performance record.
A useful preoperative conversation should be specific. Instead of asking, “Is Stryker good?” ask which Stryker implant model and bearing insert are planned, whether the procedure is total or partial knee replacement, whether the posterior cruciate ligament will be retained or substituted, and whether the patella will be resurfaced. Ask how fixation will be selected and whether the plan might change during surgery based on bone quality.
Patients with a known history of metal reactions should discuss it early. Most people with skin sensitivity to jewelry do not automatically have an implant problem, and the medical literature on metal hypersensitivity after knee replacement remains complex. Still, documented reactions, prior implant issues, or a strong allergy history may justify further evaluation and discussion of material options. Triathlon Gold may be part of that conversation for some surgeons, but it should not be treated as a universal requirement.
Patients should also ask about revision planning. Younger and more active patients may outlive their first implant. People with obesity, inflammatory disease, severe deformity, infection risk, or previous knee surgeries may have different risk profiles. The first operation matters because registry data show that early revision after primary knee replacement is associated with higher risk of further revision.
Frequently asked questions
Are Stryker knee replacement implants the best option?
No public source can support a universal “best” claim for all patients. Stryker’s Triathlon system has substantial clinical use and published survivorship data, but implant choice should be matched to anatomy, diagnosis, fixation needs, surgeon experience, and evidence for the exact construct being used.
Is Mako robotic knee replacement the same as a Stryker implant?
No. Mako is Stryker’s robotic-assisted surgery platform, while Triathlon and related components are implant systems. They are often discussed together because Triathlon Total Knee is available for use with Mako Total Knee, but the robot is a surgical planning and execution tool rather than the implant itself.
Does cementless fixation last longer than cemented fixation?
Not necessarily for every patient. Cementless fixation is increasing in U.S. primary total knee arthroplasty, while cemented fixation remains dominant in some large international registries. The better choice depends on bone quality, age, activity level, implant design, and surgeon judgment.
What should patients do if they are worried about a recall?
Patients should not assume their implant is affected based only on a brand name. They should contact their surgeon or hospital with the implant sticker, operative report, or device information if available. Recalls are often limited to specific part numbers, lot numbers, or packaging issues.
How long can a Stryker knee replacement last?
Longevity varies. AAOS states that more than 90% of modern total knee replacements are still functioning well 15 years after surgery, while registry reports provide revision benchmarks across many implant types. A surgeon can explain how those broad data apply to a patient’s specific implant, health status, and activity level.